| Aguiar, Ricardo C., MD, PhD | Molecular mechanisms of B-lymphomagenesis |
| Bishop, Alexander J., DPhil | Regulation of DNA damage response; fusion oncoproteins in children's cancers; Ewings sarcoma |
| Boyer, Thomas G., PhD | Transcriptional regulation in oncogenesis |
| Brenner, Andrew, MD, PhD | Gliomas and GBM; experimental therapeutics |
| Burma, Sandeep, PhD | DNA Damage repair pathways, glioblastoma therapy resistance |
| Chen, Yidong, PhD | Computational biology and cancer bioinformatics |
| Dahia, Patricia L., MD, PhD | Genetics and genomics of cancers especially pheochromocytomas and paragangliomas |
| Gius, David, MD, PhD | Aging, DNA damage, and carcinogenesis |
| Griffith, Ann V., PhD | Lymphopoietic stromal microenvironment in the thymus |
| Gupta, Yogesh, PhD | Combining structural biology and cell-based methods to elucidate the role of RNA modifications in cancers to develop novel therapies |
| Harris, Rueben, PhD | Infectious Disease, Biochemistry, Bioinformatics, Cell Biology, genetic engineering, molecular biology, structural biology, and virology |
| Houghton, Peter J., PhD | Pediatric cancers, sarcomas, experimental therapeutics |
| Hromas, Robert A., MD, FACP | Hematology, cancer treatment |
| Huang, Gang, PhD | Leukemia, lymphoma, renal cell carcinoma gastrointestinal stromal tumor glioma |
| Huang, Tim H-M., PhD | Epigenetic mechanisms in cancer |
| Jiang, Jean X., PhD | Cell-to-cell communication in cancer; connexins and hemi-channels |
| Jin, Lingtao, PhD | Complex signaling control mechanism underlying anti-Cancer therapy resistance |
| Kumar, A. Pratap, PhD | Nutritional intervention and prostate carcinogenesis |
| Lee, Sang Eun, PhD | Molecular genetics of DNA damage response |
| Libich David, PhD | Structural implications of EWS-FLI1 as the sole driver in Ewing’s sarcoma |
| Liu, (Jason) Zhijie, PhD | Regulation of signal-dependent gene programs in cell differentiation/dedifferentiation in the development of cancer and other diseases |
| Rao, Manjeet K., PhD | RNA interference, molecular carcinogenesis, epigenetic regulation in cancer; medulloblastoma |
| Risinger, April, PhD | Preclinical development of novel natural products for cancer treatment |
| Sareddy, Gangadhara, PhD | Hormonal signaling and epigenetic mechanisms in glioblastoma and gynecologic malignancies |
| Shiio, Yuzuru, MD, PhD | Cytokine signaling and function of fusion oncoproteins in children’s cancers; Ewing's sarcoma |
| Sun, LuZhe, PhD | Liver cancer, cancer stem cells, experimental therapeutics |
| Sun, Xiaoli, MD, PhD | Metabolic Diseases and Lipid Metabolism associated with hepatocellular carcinoma |
| Sung, Patrick, PhD | DNA Damage repair pathways |
| Vadlamudi, Ratna K., PhD | Signal transduction and steroid hormones in carcinogenesis |
| Vaseva, Angelina, PhD | Design therapeutic strategies for RAS-driven pediatric cancers. |
| Viswanadhapalli, Suryavathi, PhD | Women Cancer Progression, small molecules targeting novel oncogenes, and therapy resistance |
| Wang, Pei, PhD | pancreas biology and tumorigenesis of pancreatic cancer |
| Xu, Kexin, PhD | Epigenetic regulation, prostate cancer |
| Xu, Mingiang MD, PhD | Identifying epigenetic-focused targets for the treatment of hematologic malignancies |
| Xu, Zhenming, PhD | Differentiation and functions of B lymphocytes in antibody responses to infectious pathogens and vaccines, and cancer |
| Yang, Feng-Chun, MD, PhD | Cellular and molecular mechanisms underlying myeloid malignancies |
| Zhang, Nu, PhD | Differentiation and retention of tissue resident memory T cells and cancer |
| Zhao, Peng, PhD | metabolic homeostasis and liver cancer |
| Zhao, Weixing, PhD | BRCA1/2 biology and the implication of BRCA 1 Mutation in Triple negative breast Cancer Development |
